Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypogonadotropic hypogonadism in male newborn with micropenis
2008-008299-14Phase 3Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Mar 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in micropenis and hypogonadotropic hypogonadism (HH) comparing Testosterone monotherapy with FSH + LH combination (follitropin alfa + lutropin alfa) (2 arms). Primary endpoint: Increase in testicular volume. Started Mar 2009; status: active.
02
Drugs
testosteronefollitropin alfalutropin alfa
03
Conditions
micropenishypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on 2008-008299-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008299-14.